Michael V. McConnell, MD, MSEE

Clinical Focus

• Cardiovascular Disease
• Preventive Cardiology
• Cardiovascular Imaging

Administrative Appointments

• Director, Preventive Cardiology Clinic, Stanford (2010 - present)
• Co-Director, Noninvasive Imaging Section, Stanford Division of Cardiovascular Medicine, Stanford (2007 - present)
• Member, Molecular Imaging Program at Stanford (MIPS) Faculty, Stanford (2003 - present)
• Physician Representative, Stanford Pharmacy and Therapeutics Committee, Stanford (2001 - present)
• Director, Cardiovascular MRI Program, Stanford Division of Cardiovascular Medicine, Stanford (2000 - present)

Honors and Awards

• Research Scholarship/Aquitaine Region, Fulbright Foundation (2008)
• Diversity & Leadership Faculty Fellow, Stanford (2007)
• Department of Medicine Teaching Award, Stanford (2002)
• American Heart Association Clinician Scientist Award, Brigham & Women's Hospital/Harvard Medical School (1996)
• NHLBI Individual National Research Service Award, Brigham & Women's Hospital/Harvard Medical School (1994)

Professional Education

Postdoctoral Advisees

Catherine Dao,  Paul Kim,  Holden Wu

Graduate & Fellowship Program Affiliations

• Cardiovascular Medicine

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

Imaging cardiovascular disease, with a focus on coronary and vascular atherosclerosis and ischemic heart disease. Projects include cellular and structural characterization of atherosclerotic plaque by MRI, optical imaging (bioluminescence and fluorescence) of vascular inflammation, as well as noninvasive coronary angiography by MRI and MRI- guided cardiovascular interventions. Additional collaborative projects include real-time cardiac MRI and multi-modality imaging of cardiac stem cell transplantation.

Clinical Trials

• Abdominal Aortic Aneurysms: Simple Treatment or Prevention (AAA: STOP) Recruiting

Publications

• Acquisition and visualization of 5D respiratory-resolved cardiac MRI. Wu HH, Nishimura DG, Hu BS, McConnell MV. J Cardiovasc Magn Reson. 2012: 14 Suppl 1 P237
• Infection of Pregnant Mice with Listeria monocytogenes Induces Fetal Bradycardia. Hardy J, Kirkendoll B, Zhao H, Pisani L, Luong R, Switzer A, McConnell MV, Contag CH. Pediatr Res. 2012
• Manganese-enhanced MRI detects live human amnion-derived mesenchymal stem cells in vivo after transplantation and restoration of myocardial function in a pig ischemia-reperfusion injury model. Dash R, Toma I, Ikeno F, Lyons JK, Heidary S, Parent MC, Wang IE, Ge X, Chung J, Lam J, Kim PJ, Nakagawa K, Lyalina S, Do G, Robbins RC, McConnell MV, Yeung A, Harnish P, Yang PC. J Cardiovasc Magn Reson. 2012: 14 Suppl 1 P62
• MicroRNA-21 Blocks Abdominal Aortic Aneurysm Development and Nicotine-Augmented Expansion. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell MV, Dalman RL, Spin JM, Tsao PS. Sci Transl Med. 2012; 4 (122): 122ra22
• RGD targeting of human ferritin iron-oxide nanoparticles enhances in vivo molecular MRI of experimental aortic aneurysms. Kitagawa T, Kosuge H, Uchida M, Iida Y, Dalman RL, Douglas T, McConnell MV. J Cardiovasc Magn Reson. 2012: 14 Suppl 1 M9